Longitudinal Whole-Genome Sequence Characterization of a Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.5 Infection in an Immunocompromised Patient Successfully Treated With Sotrovimab 1000 mg

Clin Infect Dis. 2023 May 24;76(10):1872-1874. doi: 10.1093/cid/ciad090.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19*
  • Humans
  • Immunocompromised Host
  • SARS-CoV-2 / genetics

Substances

  • sotrovimab